Literature DB >> 30893423

Tissue regulatory T cells and neural repair.

Minako Ito1, Kyoko Komai1, Toshihiro Nakamura1, Tanakorn Srirat1, Akihiko Yoshimura1.   

Abstract

Inflammation and immune responses after tissue injury play pivotal roles in the pathology, resolution of inflammation, tissue recovery, fibrosis and remodeling. Regulatory T cells (Tregs) are the cells responsible for suppressing immune responses and can be activated in secondary lymphatic tissues, where they subsequently regulate effector T cell and dendritic cell activation. Recently, Tregs that reside in non-lymphoid tissues, called tissue Tregs, have been shown to exhibit tissue-specific functions that contribute to the maintenance of tissue homeostasis and repair. Unlike other tissue Tregs, the role of Tregs in the brain has not been well elucidated because the number of brain Tregs is very small under normal conditions. However, we found that Tregs accumulate in the brain at the chronic phase of ischemic brain injury and control astrogliosis through secretion of a cytokine, amphiregulin (Areg). Brain Tregs resemble other tissue Tregs in many ways but, unlike the other tissue Tregs, brain Tregs express neural-cell-specific genes such as the serotonin receptor (Htr7) and respond to serotonin. Administering serotonin or selective serotonin reuptake inhibitors (SSRIs) in an experimental mouse model of stroke increases the number of brain Tregs and ameliorates neurological symptoms. Knowledge of brain Tregs will contribute to the understanding of various types of neuroinflammation. © The Japanese Society for Immunology. 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  amphiregulin; astrogliosis; serotonin; stroke; tissue repair

Mesh:

Substances:

Year:  2019        PMID: 30893423     DOI: 10.1093/intimm/dxz031

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  17 in total

Review 1.  Regulatory T cells in ischemic stroke.

Authors:  Hong-Yun Wang; Jun-Rui Ye; Li-Yuan Cui; Shi-Feng Chu; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2021-03-26       Impact factor: 6.150

Review 2.  Adaptive Immunity Regulation and Cerebral Ischemia.

Authors:  Xingping Qin; Farhana Akter; Lingxia Qin; Jing Cheng; Mei Guo; Shun Yao; Zhihong Jian; Renzhong Liu; Songlin Wu
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

Review 3.  Transcriptional Regulation of Differentiation and Functions of Effector T Regulatory Cells.

Authors:  Shin-Ichi Koizumi; Hiroki Ishikawa
Journal:  Cells       Date:  2019-08-20       Impact factor: 6.600

4.  Subconjunctival Injection of Regulatory T Cells Potentiates Corneal Healing Via Orchestrating Inflammation and Tissue Repair After Acute Alkali Burn.

Authors:  Dan Yan; Fei Yu; Liangbo Chen; Qinke Yao; Chenxi Yan; Siyi Zhang; Nianxuan Wu; Danni Gong; Hao Sun; Yao Fu; Chunyi Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

5.  The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.

Authors:  Kyle Malone; Andrea C Diaz Diaz; Jennifer A Shearer; Anne C Moore; Christian Waeber
Journal:  J Neuroinflammation       Date:  2021-01-30       Impact factor: 8.322

Review 6.  The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke.

Authors:  Tian-Yu Lei; Ying-Ze Ye; Xi-Qun Zhu; Daniel Smerin; Li-Juan Gu; Xiao-Xing Xiong; Hong-Fei Zhang; Zhi-Hong Jian
Journal:  J Neuroinflammation       Date:  2021-01-18       Impact factor: 8.322

Review 7.  Immune Privilege: The Microbiome and Uveitis.

Authors:  Christine Mölzer; Jarmila Heissigerova; Heather M Wilson; Lucia Kuffova; John V Forrester
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

Review 8.  Regulatory T cells in ischemic stroke.

Authors:  Huan Wang; Zhao Wang; Qianqian Wu; Yujia Yuan; Wen Cao; Xiangjian Zhang
Journal:  CNS Neurosci Ther       Date:  2021-01-20       Impact factor: 5.243

9.  Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation.

Authors:  Xi Jin; Tianhai Lin; Guang Yang; Huawei Cai; Bo Tang; Xinyang Liao; Huifang Li; Xiaoting Chen; Lina Gong; Hang Xu; Yi Sun; Ping Tan; Jianqiong Yin; Hongwen Ma; Jianzhong Ai; Kunjie Wang; Qiang Wei; Lu Yang; Hong Li
Journal:  J Cell Mol Med       Date:  2020-03-19       Impact factor: 5.310

10.  Kidney GATA3+ regulatory T cells play roles in the convalescence stage after antibody-mediated renal injury.

Authors:  Ryota Sakai; Minako Ito; Kyoko Komai; Mana Iizuka-Koga; Kazuhiko Matsuo; Takashi Nakayama; Osamu Yoshie; Koichi Amano; Hiroshi Nishimasu; Osamu Nureki; Masato Kubo; Akihiko Yoshimura
Journal:  Cell Mol Immunol       Date:  2020-09-11       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.